Cargando…
The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease
INTRODUCTION: This study aimed to determine the effectiveness of adding a simple questionnaire related to musculoskeletal system to routine outpatient examination to detect undiagnosed axial and peripheral arthropathy in patients with inflammatory bowel disease (IBD). MATERIALS AND METHODS: A muscul...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947339/ https://www.ncbi.nlm.nih.gov/pubmed/36844210 http://dx.doi.org/10.3389/fmed.2023.1115362 |
_version_ | 1784892529941938176 |
---|---|
author | Keskin, Onur Farisogullari, Bayram Yardimci, Gozde Kubra Gurbuz, Burcu Kole, Melike Parlak, Erkan Karadag, Omer Kav, Taylan Kalyoncu, Umut |
author_facet | Keskin, Onur Farisogullari, Bayram Yardimci, Gozde Kubra Gurbuz, Burcu Kole, Melike Parlak, Erkan Karadag, Omer Kav, Taylan Kalyoncu, Umut |
author_sort | Keskin, Onur |
collection | PubMed |
description | INTRODUCTION: This study aimed to determine the effectiveness of adding a simple questionnaire related to musculoskeletal system to routine outpatient examination to detect undiagnosed axial and peripheral arthropathy in patients with inflammatory bowel disease (IBD). MATERIALS AND METHODS: A musculoskeletal symptom questionnaire was given to all patients with IBD during their follow-up examinations between January 2020 and November 2021. The DETAIL questionnaire consisting of six questions about the musculoskeletal system was administered by asking the patients with IBD. All patients who answered yes to at least one of these questions were directed to specialists in the rheumatology department to undergo a detailed examination. The patients who were diagnosed with rheumatological disease after further investigation were recorded. Patients with a known diagnosis of rheumatological disease were excluded from the study. FINDINGS: There were 333 patients with IBD included in the study. Of these patients, 41 (12.3%) had a previously diagnosed rheumatological disease and were excluded from the evaluation. Of the remaining 292 patients (147 with ulcerative colitis, 139 with Crohn’s disease and six with indeterminate colitis; mean age 42 years), 67 (23%) answered yes to at least one of the questions and were referred to a rheumatology consultation. Rheumatological examination was completed in 52 patients. As a result of the evaluations, 24 patients (8.2%) were diagnosed with enteropathic arthritis (14 axial, 9 peripheral, and 1 axial plus peripheral). Patients with newly diagnosed enteropathy had a lower median disease age than patients without enteropathy. CONCLUSION: The DETAIL questionnaire is an effective and easy tool for identifying missed cases of SpA in patients with IBD. |
format | Online Article Text |
id | pubmed-9947339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99473392023-02-24 The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease Keskin, Onur Farisogullari, Bayram Yardimci, Gozde Kubra Gurbuz, Burcu Kole, Melike Parlak, Erkan Karadag, Omer Kav, Taylan Kalyoncu, Umut Front Med (Lausanne) Medicine INTRODUCTION: This study aimed to determine the effectiveness of adding a simple questionnaire related to musculoskeletal system to routine outpatient examination to detect undiagnosed axial and peripheral arthropathy in patients with inflammatory bowel disease (IBD). MATERIALS AND METHODS: A musculoskeletal symptom questionnaire was given to all patients with IBD during their follow-up examinations between January 2020 and November 2021. The DETAIL questionnaire consisting of six questions about the musculoskeletal system was administered by asking the patients with IBD. All patients who answered yes to at least one of these questions were directed to specialists in the rheumatology department to undergo a detailed examination. The patients who were diagnosed with rheumatological disease after further investigation were recorded. Patients with a known diagnosis of rheumatological disease were excluded from the study. FINDINGS: There were 333 patients with IBD included in the study. Of these patients, 41 (12.3%) had a previously diagnosed rheumatological disease and were excluded from the evaluation. Of the remaining 292 patients (147 with ulcerative colitis, 139 with Crohn’s disease and six with indeterminate colitis; mean age 42 years), 67 (23%) answered yes to at least one of the questions and were referred to a rheumatology consultation. Rheumatological examination was completed in 52 patients. As a result of the evaluations, 24 patients (8.2%) were diagnosed with enteropathic arthritis (14 axial, 9 peripheral, and 1 axial plus peripheral). Patients with newly diagnosed enteropathy had a lower median disease age than patients without enteropathy. CONCLUSION: The DETAIL questionnaire is an effective and easy tool for identifying missed cases of SpA in patients with IBD. Frontiers Media S.A. 2023-02-09 /pmc/articles/PMC9947339/ /pubmed/36844210 http://dx.doi.org/10.3389/fmed.2023.1115362 Text en Copyright © 2023 Keskin, Farisogullari, Yardimci, Gurbuz, Kole, Parlak, Karadag, Kav and Kalyoncu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Keskin, Onur Farisogullari, Bayram Yardimci, Gozde Kubra Gurbuz, Burcu Kole, Melike Parlak, Erkan Karadag, Omer Kav, Taylan Kalyoncu, Umut The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease |
title | The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease |
title_full | The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease |
title_fullStr | The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease |
title_full_unstemmed | The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease |
title_short | The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease |
title_sort | detail questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947339/ https://www.ncbi.nlm.nih.gov/pubmed/36844210 http://dx.doi.org/10.3389/fmed.2023.1115362 |
work_keys_str_mv | AT keskinonur thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT farisogullaribayram thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT yardimcigozdekubra thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT gurbuzburcu thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT kolemelike thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT parlakerkan thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT karadagomer thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT kavtaylan thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT kalyoncuumut thedetailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT keskinonur detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT farisogullaribayram detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT yardimcigozdekubra detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT gurbuzburcu detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT kolemelike detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT parlakerkan detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT karadagomer detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT kavtaylan detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease AT kalyoncuumut detailquestionnaireisausefulandeffectivetooltoassessspondyloarthritisinpatientswithinflammatoryboweldisease |